Risk Indicators for Hearing Impairment in Neonates

• Published in: Indian journal of otolaryngology, and head, and neck surgery Vol. 72; no. 1; pp. 55 - 58
• Main Authors: Panjiyar, Megha M., Bhargava, Samir K., Gite, Vinod, Shetty, Neeraj R., Mhashal, Shashikant
• Format: Journal Article
• Language: English
• Published: New Delhi Springer India 01.03.2020; Springer Nature B.V
• Subjects: Head and Neck Surgery; Health risk assessment; Hearing loss; Medicine; Medicine & Public Health; Original; Original Article; Otorhinolaryngology; Risk factors; Profound SNHL; Cost effective screening; High risk neonates; Hearing impairment; Risk factors
• ISSN: 2231-3796; 0973-7707
• DOI: 10.1007/s12070-019-01735-6

To identify relation between prevalence of hearing impairment and risk factors at the time of birth in high risk neonates. A year-long study is performed at HBT Medical College and Dr. R. N. Cooper Municipal General Hospital, Vile Parle (west), Mumbai. The Study comprised of 478 high risk babies born between March 2016 and February 2017 and admitted in NICU of the hospital. Out of these 68 babies were either transferred to higher centre or took discharge against medical advice. A total of 410 babies completed the study. Additional 21 eligible babies died in NICU during the study. A Prospective Observational Study is used to analyse the findings of the study. Skew analysis of spread of prevalence across risk factors is used to establish higher prevalence of hearing impairment in high risk neonates. Cramer’s Moment Coefficient of Skewness and Corresponding Test Statistics are used for studying the skewness. Out of 410 babies screened during the study 5 babies were diagnosed with profound SNHL. The risk factors associated with babies is plotted against frequency of babies with Profound SNHL. The plot is found to be un-uniformly distributed and shows inclination towards higher prevalence with high risk babies. Sample skewness (G 1 ) value − 0.81 indicates moderately negative skewed sample. This means the number of babies with profound SNHL found by 3 stage screening is moderately concentrated at high risk weightage.